DECREASES IN ETHANOL CONSUMPTION PRODUCED BY BIFUNCTIONAL MU OPIOID, NOCICEPTIN/ORPHANIN FQ PEPTIDE (NOP) RECEPTOR AGONISTS IN MONKEYS

被引:0
|
作者
Czoty, P. W. [1 ]
Epperly, P. M. [1 ]
Davenport, A. T. [1 ]
Ko, M. C. [1 ]
Husbands, S. M. [1 ]
Flynn, S. M. [1 ]
机构
[1] Wake Forest Sch Med, Dept Physiol & Pharmacol, Winston Salem, NC 27157 USA
关键词
D O I
暂无
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
515
引用
收藏
页码:147A / 147A
页数:1
相关论文
共 50 条
  • [1] Effects of stimulation of mu opioid and nociceptin/orphanin FQ peptide (NOP) receptors on alcohol drinking in rhesus monkeys
    Shawn M. Flynn
    Phillip M. Epperly
    April T. Davenport
    Gerta Cami-Kobeci
    Stephen M. Husbands
    Mei-Chuan Ko
    Paul W. Czoty
    [J]. Neuropsychopharmacology, 2019, 44 : 1476 - 1484
  • [2] Effects of stimulation of mu opioid and nociceptin/orphanin FQ peptide (NOP) receptors on alcohol drinking in rhesus monkeys
    Flynn, Shawn M.
    Epperly, Phillip M.
    Davenport, April T.
    Cami-Kobeci, Gerta
    Husbands, Stephen M.
    Ko, Mei-Chuan
    Czoty, Paul W.
    [J]. NEUROPSYCHOPHARMACOLOGY, 2019, 44 (08) : 1476 - 1484
  • [3] NOCICEPTIN/ORPHANIN FQ OPIOID PEPTIDE (NOP) RECEPTOR EXPRESSION IN PACHYONYCHIA CONGENITA (PC)
    Pan, B.
    Schroeder, W.
    Jostock, R.
    Schwartz, M.
    Polydefkis, M.
    [J]. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2017, 22 (03) : 353 - 353
  • [4] Effects of BU08028, a Mixed Mu Opioid Receptor and Nociceptin/Orphanin FQ Peptide (NOP) Receptor Agonist, on Alcohol Drinking in Rhesus Monkeys
    Czoty, Paul
    Epperly, Phillip
    Davenport, April
    Ko, Mei-Chuan
    Husbands, Stephen
    Flynn, Shawn
    [J]. NEUROPSYCHOPHARMACOLOGY, 2017, 42 : S630 - S630
  • [5] Nociceptin/Orphanin FQ Receptor Activation Attenuates Antinociception Induced by Mixed Nociceptin/Orphanin FQ/μ-Opioid Receptor Agonists
    Khroyan, Taline V.
    Polgar, Willma E.
    Jiang, Faming
    Zaveri, Nurulain T.
    Toll, Lawrence
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2009, 331 (03): : 946 - 953
  • [6] Cebranopadol: A Novel Potent Analgesic Nociceptin/Orphanin FQ Peptide and Opioid Receptor Agonists
    Linz, Klaus
    Christoph, Thomas
    Tzschentke, Thomas M.
    Koch, Thomas
    Schiene, Klaus
    Gautrois, Michael
    Schroeder, Wolfgang
    Koegel, Babette Y.
    Beier, Horst
    Englberger, Werner
    Schunk, Stefan
    De Vry, Jean
    Jahnel, Ulrich
    Frosch, Stefanie
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2014, 349 (03): : 535 - 548
  • [7] Heterodimerization of mu opioid receptor and nociceptin/orphanin FQ peptide receptor alters g protein coupling
    Gunduz, O.
    Baldini, E.
    Borsodi, A.
    Benyhe, S.
    Corbani, M.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 : S280 - S281
  • [8] Mu-opioid peptide (MOP) and nociceptin/orphanin FQ peptide (NOP) receptor activation both contribute to the discriminative stimulus properties of cebranopadol in the rat
    Tzschentke, Thomas M.
    Rutten, Kris
    [J]. NEUROPHARMACOLOGY, 2018, 129 : 100 - 108
  • [9] Role of nociceptin/orphanin FQ and nociceptin opioid peptide receptor in depression and antidepressant effects of nociceptin opioid peptide receptor antagonists
    Park, Jong Yung
    Chae, Suji
    Kim, Chang Seop
    Kim, Yoon Jae
    Yi, Hyun Joo
    Han, Eunjoo
    Joo, Youngshin
    Hong, Surim
    Yun, Jae Won
    Kim, Hyojung
    Shin, Kyung Ho
    [J]. KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY, 2019, 23 (06): : 427 - 448
  • [10] Mixed mu-nociceptin/orphanin FQ opioid receptor agonists and the search for the analgesic holy grail
    Lambert, David G.
    [J]. BRITISH JOURNAL OF ANAESTHESIA, 2019, 122 (06) : E95 - E97